Page 48 - ESHRE2019

46
Esteves, 44
Esteves, 44
•• ••
   • • 
Oral antioxidant therapy
.  . .  .  . 
. • • .  . 
.  .  • • . 
.  . 
Treatment of underlying condition(s)
  • •

 • •
Hormonal therapy
. • •• • 
Assisted Reproductive Technology

• • 
 • •• •

• •• •• •
• •
Conclusions (1)
1. Sperm DNA damage associated with infertility and impaired reproductive outcomes.
2. Sperm DNA damage testing provides invaluable information about the sperm chromatin at molecular level.
3. Among existing assays, those assessing SDF more relevant owing to the association between male infertility conditions and oxidative stress.
4. Fair evidence supports the clinical utility of SDF testing in specific clinical scenarios.
42
From Esteves, Santi & Simoni. Andrology, submitted
Esteves, 43